Sector ETF report for XBI
Smart Beta ETF report for XBI
Sector ETF report for XBI
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 12-month high of $100.00. Approximately 748,000 shares have changed hands today, as compared to an average 30-day volume of 1.4 million shares....
Investors need to pay close attention to Arena (ARNA) stock based on the movements in the options market lately.
While the sector is under pressure, these biotech stocks have key catalysts in March
Morning Markets March S&P 500 futures this morning gave up an overnight rally and are down by -0.18%. Stocks indexes retreated this morning as crude prices jumped more than +4% after Bloomberg reported...
Arena Pharmaceuticals (ARNA) misses on Q4 bottom line. Top-line data from several phase III studies on etrasimod are slated for release in 2022.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021.
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced that the Compensation Committee of its Board of Directors granted to 18 new employees 18,527 inducement restricted stock units ("RSUs"). The...